Standardizing the reporting of postoperative hypoparathyroidism following thyroidectomy: consensus statement from the European Society of Endocrine Surgeons, the American Association of Endocrine Surgeons, and the International Association of Endocrine Surgeons

作者：Marcin Barczyński, Klaas Van Den Heede, James C. Lee, Kerstin Lorenz, Radu Mihai, Olov Norlén, Kepal N. Patel, Marco Raffaelli, Rebecca S. Sippel, Tracy Wang, Carmen C. Solórzano · 发表于：British journal of surgery · 年份：2025 · DOI：10.1093/bjs/znaf247 · 被引用次数：13 · 研究领域：Thyroid and Parathyroid Surgery、Thyroid Cancer Diagnosis and Treatment、Thyroid Disorders and Treatments

Postoperative hypoparathyroidism remains the most frequent complication following thyroid surgery, with reported incidence rates ranging from 14% to 60%1–7. While the majority of cases are transient and resolve within weeks, a substantial proportion (up to 25%) progress to persistent hypoparathyroidism, defined by sustained reductions in parathyroid hormone (PTH) and serum calcium levels beyond 6–12 months after surgery1,2,4,5. Despite its prevalence and clinical impact, postoperative hypoparathyroidism continues to be variably defined across studies and institutions. Terminology such as ‘postoperative parathyroid failure’, ‘protracted hypoparathyroidism’, and ‘permanent hypoparathyroidism’ has been proposed to reflect the temporal evolution of the condition6,7. However, the lack of standardized definitions and reporting criteria has hindered meaningful comparisons across clinical studies and limited the development of consistent management strategies7. Current approaches to hypoparathyroidism management range from short-term calcium and activated vitamin D supplementation to long-term replacement therapy and monitoring protocols7. These variations underscore the need for a unified framework to guide diagnosis, classification, and treatment. In addition to harmonizing definitions, there is a critical need to identify and standardize core variables that should be reported in surgical research related to hypoparathyroidism. These include biochemical parameters (for example PTH ...